{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T21:22:56Z","timestamp":1781040176952,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008493","name":"V\u00e4in\u00f6 and Laina Kivi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006706","name":"Tampere Tuberculosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007634","name":"Ida Montin S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007634","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jacig.2024.100268","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T01:14:59Z","timestamp":1714180499000},"page":"100268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of fluticasone propionate\/formoterol and fluticasone furoate\/vilanterol on adolescents with chronic bronchial obstruction"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1444-0173","authenticated-orcid":false,"given":"Tiina Helena","family":"Tanninen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Susanna","family":"Pelkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo Pekka","family":"Malmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika Juhani","family":"M\u00e4kel\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl\u00a05","key":"10.1016\/j.jacig.2024.100268_bib2","first-page":"S94","article-title":"Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007","volume":"120","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100268_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/thorax-2021-217032","article-title":"Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study","volume":"78","author":"Soremekun","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.jacig.2024.100268_bib4","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa1513737","article-title":"Patterns of growth and decline in lung function in persistent childhood asthma","volume":"374","author":"McGeachie","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2024.100268_bib5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ACI.0000000000000348","article-title":"Childhood asthma is a risk factor for the development of chronic obstructive pulmonary disease","volume":"17","author":"McGeachie","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100268_bib6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jaci.2006.07.053","article-title":"Mild to moderate asthma affects lung growth in children and adolescents","volume":"118","author":"Strunk","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100268_bib7","doi-asserted-by":"crossref","first-page":"00154","DOI":"10.1183\/23120541.00154-2022","article-title":"Lung function in young adulthood: differences between males and females with asthma","volume":"8","author":"Mogensen","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jacig.2024.100268_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018186","article-title":"Effectiveness of inhaled corticosteroids in real life on clinical outcomes, sputum cells and systemic inflammation in asthmatics: a retrospective cohort study in a secondary care centre","volume":"7","author":"Demarche","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacig.2024.100268_bib10","doi-asserted-by":"crossref","first-page":"5949","DOI":"10.1038\/s41598-022-09941-z","article-title":"Comparative efficacy of inhalers in mild-to-moderate asthma: systematic review and network meta-analysis","volume":"12","author":"Park","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacig.2024.100268_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40267-019-00635-7","article-title":"K-haler breath-triggered inhaler: a profile of the properties of the device","volume":"35","author":"Deeks","year":"2019","journal-title":"Drugs Ther Perspect"},{"key":"10.1016\/j.jacig.2024.100268_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.rmed.2018.06.009","article-title":"Efficacy and safety of once-daily fluticasone furoate\/vilanterol (FF\/VI) versus twice-daily inhaled corticosteroids\/long-acting \u03b22-agonists (ICS\/LABA) in patients with uncontrolled asthma: an open-label, randomized, controlled trial","volume":"141","author":"Devillier","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.jacig.2024.100268_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/jamp.2015.1223","article-title":"The ELLIPTA dry powder inhaler: design, functionality, in\u00a0vitro dosing performance and critical task compliance by patients and caregivers","volume":"28","author":"Grant","year":"2015","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"10.1016\/j.jacig.2024.100268_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s41030-017-0036-4","article-title":"Aerosol deposition of inhaled corticosteroids\/long-acting \u03b22-agonists in the peripheral airways of patients with asthma using functional respiratory imaging, a novel imaging technology","volume":"3","author":"Iwanaga","year":"2017","journal-title":"Pulm Ther"},{"key":"10.1016\/j.jacig.2024.100268_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.rmed.2018.03.029","article-title":"Pulmonary deposition of fluticasone propionate\/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler","volume":"138","author":"Kappeler","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.jacig.2024.100268_bib16","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2024.100268_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00753-2019","article-title":"Technical standards for respiratory oscillometry","volume":"55","author":"King","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2024.100268_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2024.100268_bib20","first-page":"395","article-title":"Terveiden suomalaislasten spirometrian ja uloshengityksen huippuvirtauksen viitearvot","author":"Koillinen","year":"1998","journal-title":"Suomen L\u00e4\u00e4k\u00e4rilehti"},{"key":"10.1016\/j.jacig.2024.100268_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100268_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1183\/09031936.00.15101100","article-title":"Low- and high-dose fluticasone propionate in asthma; effects during and after treatment","volume":"15","author":"Gershman","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2024.100268_bib23","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jaci.2005.09.024","article-title":"Irreversible lung function deficits in young adults with a history of childhood asthma","volume":"116","author":"Limb","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100268_bib24","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/ACI.0000000000000728","article-title":"Small-airway dysfunction in paediatric asthma","volume":"21","author":"Cottini","year":"2021","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100268_bib25","doi-asserted-by":"crossref","DOI":"10.5415\/apallergy.2020.10.e3","article-title":"Forced oscillation technique as a predictor for loss of control in asthmatic children","volume":"10","author":"Kreetapirom","year":"2020","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.jacig.2024.100268_bib26","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S2213-2600(19)30049-9","article-title":"Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study","volume":"7","author":"Postma","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacig.2024.100268_bib27","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S2213-2600(21)00536-1","article-title":"The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study","volume":"10","author":"Kraft","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jacig.2024.100268_bib28","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1164\/rccm.201110-1922OC","article-title":"Interaction between asthma and lung function growth in early life","volume":"185","author":"Bisgaard","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2024.100268_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ppul.21190","article-title":"Factors in infancy and childhood related to reduced lung function in asthmatic children: a birth cohort study (BAMSE): factors in infancy and childhood related to lung function","volume":"45","author":"Hallberg","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jacig.2024.100268_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.202203-0444OC","article-title":"Plasticity of individual lung function states from childhood to adulthood","volume":"207","author":"Wang","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2024.100268_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/thoraxjnl-2020-215884","article-title":"Early-life risk factors for reversible and irreversible airflow limitation in young adults: findings from the BAMSE birth cohort","volume":"76","author":"Wang","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jacig.2024.100268_bib32","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1164\/rccm.2108009","article-title":"Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV 1\/vital capacity ratio: a longitudinal population study from childhood to adulthood","volume":"165","author":"Rasmussen","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2024.100268_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1034\/j.1399-3003.2000.16b08.x","article-title":"Optimal asthma control, starting with high doses of inhaled budesonide","volume":"16","author":"Reddel","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jacig.2024.100268_bib34","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/cea.14112","article-title":"Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: a systematic review and meta-analysis","volume":"52","author":"Charles","year":"2022","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2024.100268_bib35","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/thoraxjnl-2013-204815","article-title":"The association between childhood asthma and adult chronic obstructive pulmonary disease","volume":"69","author":"Tai","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jacig.2024.100268_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.898208","article-title":"Fixed airflow obstruction in asthma: a problem of the whole lung not of just the airways","volume":"13","author":"Rutting","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.jacig.2024.100268_bib37","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.21037\/jtd-19-3913","article-title":"Real-life effectiveness of fluticasone furoate\/vilanterol after switching from fluticasone\/salmeterol or budesonide\/formoterol therapy in patients with symptomatic asthma: Relvar Ellipta for Real Asthma Control Study (RERACS study)","volume":"12","author":"Shimizu","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jacig.2024.100268_bib38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4155\/tde-2017-0037","article-title":"Drug delivery to the lungs: challenges and opportunities","volume":"8","author":"Newman","year":"2017","journal-title":"Ther Deliv"},{"key":"10.1016\/j.jacig.2024.100268_bib39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/pai.12491","article-title":"Extra-fine particle inhaled corticosteroids, pharma-cokinetics and systemic activity in children with asthma","volume":"27","author":"Wolthers","year":"2016","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jacig.2024.100268_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/1753466618760948","article-title":"Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid\/long-acting \u03b22-agonists delivered via a pressurized metered-dose inhaler","volume":"12","author":"Van Holsbeke","year":"2018","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.jacig.2024.100268_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s13556-013-0003-9","article-title":"Fine particle profile of fluticasone propionate\/formoterol fumarate versus other combination products: the DIFFUSE Study","volume":"3","author":"Johal","year":"2013","journal-title":"Comb Prod Ther"},{"key":"10.1016\/j.jacig.2024.100268_bib42","series-title":"deposition and particle size of","author":"Lung","year":"2014"},{"key":"10.1016\/j.jacig.2024.100268_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/JAA.S233268","article-title":"Treatment adherence in adolescents with asthma","volume":"13","author":"Kaplan","year":"2020","journal-title":"J Asthma Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277282932400064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277282932400064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T08:05:54Z","timestamp":1725091554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277282932400064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S277282932400064X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100268","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of fluticasone propionate\/formoterol and fluticasone furoate\/vilanterol on adolescents with chronic bronchial obstruction","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100268","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100268"}}